On December 31, 2009, Vertex Pharmaceuticals (VRTX) had a market capitalization of $8.5B, based on 198.94M shares at a price of $42.85.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 31 2009 | $42.85 | 864,451 | 198,935,000 | $8,524,364,750.00 |
December 30 2009 | $43.55 | 921,494 | 198,935,000 | $8,663,619,250.00 |
December 29 2009 | $43.35 | 1,081,774 | 198,935,000 | $8,623,832,250.00 |
December 28 2009 | $43.22 | 742,011 | 198,935,000 | $8,597,970,700.00 |
December 24 2009 | $43.04 | 283,056 | 198,935,000 | $8,562,162,400.00 |
December 23 2009 | $42.65 | 1,174,222 | 198,935,000 | $8,484,577,750.00 |
December 22 2009 | $42.90 | 1,471,073 | 198,935,000 | $8,534,311,500.00 |
December 21 2009 | $42.15 | 2,016,599 | 198,935,000 | $8,385,110,250.00 |
December 18 2009 | $42.34 | 5,747,317 | 198,935,000 | $8,422,907,900.00 |
December 17 2009 | $41.13 | 2,574,243 | 198,935,000 | $8,182,196,550.00 |
December 16 2009 | $42.51 | 2,827,181 | 198,935,000 | $8,456,726,850.00 |
December 15 2009 | $41.56 | 3,132,929 | 198,935,000 | $8,267,738,600.00 |
December 14 2009 | $40.60 | 1,432,210 | 198,935,000 | $8,076,761,000.00 |
December 11 2009 | $39.90 | 1,350,011 | 198,935,000 | $7,937,506,500.00 |
December 10 2009 | $40.29 | 1,453,942 | 198,935,000 | $8,015,091,150.00 |
December 09 2009 | $40.18 | 1,868,038 | 198,935,000 | $7,993,208,300.00 |
December 08 2009 | $39.82 | 1,725,150 | 198,935,000 | $7,921,591,700.00 |
December 07 2009 | $39.19 | 1,299,797 | 198,935,000 | $7,796,262,650.00 |
December 04 2009 | $39.63 | 2,292,614 | 198,935,000 | $7,883,794,050.00 |
December 03 2009 | $40.22 | 7,633,150 | 198,935,000 | $8,001,165,700.00 |
December 02 2009 | $39.49 | 1,404,348 | 198,935,000 | $7,855,943,150.00 |
December 01 2009 | $39.86 | 1,781,890 | 198,935,000 | $7,929,549,100.00 |
November 30 2009 | $38.82 | 1,597,378 | 198,935,000 | $7,722,656,700.00 |
November 27 2009 | $39.00 | 544,910 | 198,935,000 | $7,758,465,000.00 |
November 25 2009 | $39.38 | 906,461 | 198,935,000 | $7,834,060,300.00 |
